Natick, MA, United States of America

Donald W Euwart

This inventor holds 1 USPTO granted patent. Top assignee: Hybridon, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald W Euwart. Retrieved from https://idiyas.com/inventor/donald-w-euwart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Donald W. Euwart

Introduction

Donald W. Euwart is a notable inventor based in Natick, MA (US). He has made significant contributions to the field of oligonucleotide synthesis. His work focuses on optimizing the processes involved in this complex area of research.

Latest Patents

Euwart holds a patent for an "Apparatus and process for multi-stage solid phase synthesis of long." This invention involves an apparatus and process designed to enhance the repetitive steps in solid-phase oligonucleotide synthesis. The innovation utilizes continuous optical scanning of the effluent stream from the reaction module, along with computerized processing and implementation of the scanning data. He has 1 patent to his name.

Career Highlights

Throughout his career, Euwart has been associated with Hybridon, Inc., a company known for its advancements in biotechnology. His work has contributed to the development of more efficient methods in the synthesis of oligonucleotides, which are essential for various applications in genetic research and therapeutics.

Collaborations

Euwart has collaborated with notable colleagues such as Edward Ashare and Hubert Koster. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in the field of biotechnology.

Conclusion

Donald W. Euwart's contributions to the field of oligonucleotide synthesis exemplify the impact of innovative thinking in biotechnology. His patent and work at Hybridon, Inc. highlight the importance of continuous improvement in scientific processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…